Johanna Räikkönen

423 total citations
8 papers, 348 citations indexed

About

Johanna Räikkönen is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Johanna Räikkönen has authored 8 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Molecular Biology and 2 papers in Cancer Research. Recurrent topics in Johanna Räikkönen's work include Bone health and treatments (5 papers), Cancer, Lipids, and Metabolism (2 papers) and Electrohydrodynamics and Fluid Dynamics (1 paper). Johanna Räikkönen is often cited by papers focused on Bone health and treatments (5 papers), Cancer, Lipids, and Metabolism (2 papers) and Electrohydrodynamics and Fluid Dynamics (1 paper). Johanna Räikkönen collaborates with scholars based in Finland, France and United Kingdom. Johanna Räikkönen's co-authors include Jukka Mönkkönen, Hannu Mönkkönen, Seppo Auriola, Olivier Henry, Hong Wang, Craig T. Morita, Yen-Chih Wang, Yoshimasa Tanaka, Mark D. Distefano and Julie C. Crockett and has published in prestigious journals such as The Journal of Immunology, Biochemical and Biophysical Research Communications and British Journal of Pharmacology.

In The Last Decade

Johanna Räikkönen

8 papers receiving 345 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Johanna Räikkönen Finland 8 138 137 119 56 39 8 348
Hussein Sultan United States 11 189 1.4× 288 2.1× 145 1.2× 28 0.5× 14 0.4× 20 388
Ismahène Benzaïd France 6 329 2.4× 118 0.9× 98 0.8× 134 2.4× 41 1.1× 10 454
Philippos Demetriou United Kingdom 6 116 0.8× 163 1.2× 102 0.9× 19 0.3× 30 0.8× 6 371
Aaron T. Alpar United States 10 190 1.4× 232 1.7× 166 1.4× 53 0.9× 12 0.3× 18 454
Vincenzo Ingangi Italy 12 120 0.9× 102 0.7× 142 1.2× 13 0.2× 86 2.2× 15 323
Brian J. Mog United States 6 169 1.2× 132 1.0× 124 1.0× 39 0.7× 49 1.3× 10 291
Annelie Lindström Sweden 10 152 1.1× 105 0.8× 107 0.9× 85 1.5× 64 1.6× 17 424
Jennifer Sun United States 9 138 1.0× 146 1.1× 138 1.2× 50 0.9× 27 0.7× 17 373

Countries citing papers authored by Johanna Räikkönen

Since Specialization
Citations

This map shows the geographic impact of Johanna Räikkönen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johanna Räikkönen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johanna Räikkönen more than expected).

Fields of papers citing papers by Johanna Räikkönen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johanna Räikkönen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johanna Räikkönen. The network helps show where Johanna Räikkönen may publish in the future.

Co-authorship network of co-authors of Johanna Räikkönen

This figure shows the co-authorship network connecting the top 25 collaborators of Johanna Räikkönen. A scholar is included among the top collaborators of Johanna Räikkönen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johanna Räikkönen. Johanna Räikkönen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Mönkkönen, Hannu, Johanna Räikkönen, Ismahène Benzaïd, et al.. (2014). Upregulation of the mevalonate pathway by cholesterol depletion abolishes tolerance to N-bisphosphonate induced Vγ9Vδ2 T cell cytotoxicity in PC-3 prostate cancer cells. Cancer Letters. 357(1). 279–285. 9 indexed citations
2.
Wang, Hong, Olivier Henry, Mark D. Distefano, et al.. (2013). Butyrophilin 3A1 Plays an Essential Role in Prenyl Pyrophosphate Stimulation of Human Vγ2Vδ2 T Cells. The Journal of Immunology. 191(3). 1029–1042. 121 indexed citations
3.
Elomaa, Matti, et al.. (2012). Viability of freeze dried microencapsulated human retinal pigment epithelial cells. European Journal of Pharmaceutical Sciences. 47(2). 520–526. 18 indexed citations
4.
Giger, Elisabeth V., Bastien Castagner, Johanna Räikkönen, Jukka Mönkkönen, & Jean‐Christophe Leroux. (2012). siRNA Transfection with Calcium Phosphate Nanoparticles Stabilized with PEGylated Chelators. Advanced Healthcare Materials. 2(1). 134–144. 49 indexed citations
5.
Räikkönen, Johanna, et al.. (2011). Correlation between time-dependent inhibition of human farnesyl pyrophosphate synthase and blockade of mevalonate pathway by nitrogen-containing bisphosphonates in cultured cells. Biochemical and Biophysical Research Communications. 407(4). 663–667. 14 indexed citations
6.
Räikkönen, Johanna, Hannu Mönkkönen, Seppo Auriola, & Jukka Mönkkönen. (2009). Mevalonate pathway intermediates downregulate zoledronic acid-induced isopentenyl pyrophosphate and ATP analog formation in human breast cancer cells. Biochemical Pharmacology. 79(5). 777–783. 40 indexed citations
7.
Räikkönen, Johanna, Julie C. Crockett, Michael J. Rogers, et al.. (2009). Zoledronic acid induces formation of a pro‐apoptotic ATP analogue and isopentenyl pyrophosphate in osteoclasts in vivo and in MCF‐7 cells in vitro. British Journal of Pharmacology. 157(3). 427–435. 65 indexed citations
8.
Jauhiainen, Marjo, Hannu Mönkkönen, Johanna Räikkönen, Jukka Mönkkönen, & Seppo Auriola. (2009). Analysis of endogenous ATP analogs and mevalonate pathway metabolites in cancer cell cultures using liquid chromatography–electrospray ionization mass spectrometry. Journal of Chromatography B. 877(27). 2967–2975. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026